CCCC
C4 Therapeutics Inc
3.30$
-2.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 147.7% | 222.9% | 236.3% | 6.3% | 24.4% | 37.3% | 22.2% | 22.2% | |
| -47.7% | 100.0% | -136.3% | 100.0% | 100.0% | 62.7% | 100.0% | 77.8% | |
| 147.7% | 224.8% | 236.3% | 206.8% | 379.0% | 567.1% | 310.9% | 290.0% | |
| 37.0% | 41.0% | 45.8% | 72.6% | 137.6% | 202.7% | 118.4% | 100.7% | |
| 184.6% | 265.8% | 45.8% | 279.4% | 516.6% | 732.6% | 436.1% | 368.5% | |
| -84.6% | -165.8% | -182.1% | -179.4% | -416.6% | -669.8% | -336.1% | -290.7% | |
| 0.0% | 10.1% | 3.7% | 4.7% | 7.1% | 6.6% | 0.0% | – | |
| -81.1% | -155.7% | -197.9% | -183.2% | -412.2% | -632.2% | -295.6% | -291.7% | |
| 3.5% | 3.8% | 1.9% | 4.7% | -5.4% | 6.2% | 0.4% | 0.3% | |
| -81.1% | -159.5% | -199.8% | -183.2% | -412.2% | -638.3% | -296.0% | -292.1% | |
| -78.1% | -148.3% | -177.2% | -175.3% | -399.7% | -588.3% | -290.5% | -286.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.